Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease
Movement Disorders · 2026
DOI: 10.1002/mds.70446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Han Kyu Na und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korean National Institute of Health, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Concurrent Alzheimer's disease pathology is increasingly recognized as a poor prognostic factor in Parkinson's disease (PD), yet reliable clinical indicators for early identification of AD copathology remain poorly established.
Objective
To investigate baseline motor and nonmotor symptom profiles associated with amyloid‐β (Aβ) copathology in newly diagnosed PD.
Methods
Among patients with PD who underwent Aβ imaging, we retrospectively identified 152 patients who completed the Cross‐Cultural Smell Identification Test (CC‐SIT), autonomic function tests, neuropsychological assessment, and Neuropsychiatric Inventory Questionnaire (NPI‐Q) at drug‐naive state. Predictors of Aβ positivity were identified using stepwise multivariable logistic regression and validated with Random Forest classifiers employing Boruta feature selection.
Results
Compared with Aβ‐negative counterparts (n = 93), Aβ‐positive (Aβ + PD, n = 59) patients demonstrated greater olfactory dysfunction (CC‐SIT, P = 0.002), dysautonomia (Composite Autonomic Severity Scale [CASS], P < 0.001), and mood disturbance (NPI‐Q‐mood, P < 0.001) and higher prevalence of probable rapid eye movement sleep behavior disorder ( P = 0.009) and neurogenic orthostatic hypotension ( P = 0.006). Aβ + PD patients showed greater motor disability (Unified Parkinson's Disease Rating Scale Part III [UPDRS‐III], P < 0.001) despite comparable striatal dopamine transporter uptake. Logistic regression identified lower CC‐SIT scores (odds ratio [OR] = 0.821, 95% confidence interval [CI 95% ]: 0.703–0.959), higher CASS scores (OR = 1.380, CI 95% : 1.144–1.666), higher NPI‐Q‐mood scores (OR = 1.057, CI 95% : 1.005–1.111), higher UPDRS‐III (OR = 1.080, CI 95% : 1.030–1.132), and APOE ε4 carrier status (OR = 3.643, CI 95% : 1.479–8.969) as independent predictors of Aβ positivity, which were also confirmed as important variables by Boruta feature selection.
Conclusions
Our findings suggest that greater motor and nonmotor symptom burden at diagnosis, characterized by olfactory/autonomic dysfunction, mood disturbance, and motor deficits disproportionate to dopaminergic denervation, was associated with Aβ positivity in PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Neurology, Inje University Sanggye Paik Hospital, Seoul, South Korea.
- Department of Physiology, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Neurology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
- Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, South Korea.
ORCID-Profile: Yeeun Sun, Jung Hyun Lee, Seok Jong Chung, Chul Hyoung Lyoo, Phil Hyu Lee
Förderung
- Korean National Institute of Health
- National Research Foundation of Korea
Zitieren
APA
Na, H. K., Sun, Y., Park, C. W., Lee, J. H., Choi, Y. Y., Vo, Q. P., Chung, S. J., Yoo, H. S., Lyoo, C. H., Sohn, Y. H., Hong, J. Y., & Lee, P. H. (2026). Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70446
Vancouver
Na HK, Sun Y, Park CW, Lee JH, Choi YY, Vo QP, et al. Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70446
BibTeX
@article{Na2026,
author = {Na, Han Kyu and Sun, Yeeun and Park, Chan Wook and Lee, Jung Hyun and Choi, Yun Young and Vo, Quynh Phuong and Chung, Seok Jong and Yoo, Han Soo and Lyoo, Chul Hyoung and Sohn, Young H and Hong, Jin Yong and Lee, Phil Hyu},
title = {Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70446}
}
EUVIMED